Background/Aims: Low back pain is a common and disabling symptom that has not been properly studied in hemodialysis patients. The aim of this study was to evaluate factors associated with chronic low back pain in these patients. Methods: We evaluated 205 patients undergoing chronic hemodialysis. Data were obtained through medical records, patient interviews and physical examination. Balance was evaluated through the Tinetti scale. The muscular strength was evaluated through the quadriceps muscle manual test and the Kendall scale graduation. Results: 74 patients (36.1%) had low back pain. They were older (p = 0.020), undergoing dialysis for a longer period (p = 0.071) and had more comorbidities than patients without lumbar pain. Among the patients with low back pain, 75.7% presented balance disorders and 59.5% muscular weakness. In multivariate analysis the factors related to low back pain were balance deficit (OR: 9.30; 95% CI: 2.77–31.20), muscular strength deficit (OR: 14.33; 95% CI: 4.55–45.19), arterial hypertension (OR: 4.51; 95% CI: 1.32–15.37), bone disease (OR: 43.39; 95% CI: 11.51–163.53) and cerebrovascular disease (OR: 20.21; 95% CI: 3.28–124.65). Conclusions: Chronic low back pain is common in hemodialysis patients and is associated with muscle weakness, balance disorders, and comorbidities.

1.
Strine TW, Hootman JM: US National prevalence and correlates of low back and neck pain among adults. Arthritis Rheum 2007;57:656–665.
2.
Addison R, Schultz A: Trunk strengths in patients seeking hospitalization for chronic low-back disorders. Spine 1980;5:539–544.
3.
Thomas E, Silman AJ, Croft PR, Papageorgion AC, Jayson MI, MacFarlane GJ: Predicting who develops chronic low back pain in primary care: a prospective study. BMJ 1999;318:1662–1667.
4.
Johansen KL, Chertow GM, Mulligan K, Carey S, Schoenfeld PY, Kent-Braun JA: Physical activity levels in patients on hemodialysis and healthy controls. Kidney Int 2000;57:2564–2570.
5.
Storer TW, Casaburi R, Sawelson S, Kopple JD: Endurance exercise training during haemodialysis improves strength, power, fatigability and physical performance in maintenance haemodialysis patients. Nephrol Dial Transplant 2005;20:1429–1437.
6.
Mayer G, Thum J, Graf H: Anaemia and reduced exercise capacity in patients on chronic hemodialysis. Clin Sci 1989;76:265–273.
7.
Henrotin EY, Cedraschi C, Duplan B, Bazin T, Duquesnoy B: Information and low back pain management: a systematic review. Spine 2006;31:E326–E334.
8.
Koes BW, van Tulder MW, Thomas S: Diagnosis and treatment of low back pain. BMJ 2006;332:1430–1434.
9.
Tinetti ME, Speechley M, Ginter SF: Risk factors for falls among elderly persons living in the community. N Engl J Med 1988;319:1701–1707.
10.
Johansen K, Painter P, Kent-Braun J, et al: Validation of questionnaires to estimate physical activity and functioning in ESRD. Kidney Int 2001;59:1121–1127.
11.
Williams GN, Chmielewski T, Rudolph K, Buchanan TS, Snyder-Mackler L: Dynamic knee stability: current theory and implications for clinicians and scientists. J Orthop Sports Phys Ther 2001;31:546–566.
12.
Katz S, Ford AB, Moskowitz RW, Jackson BA, Jaffe MW: Studies of illness in the aged. The index of ADL: a standardized measure of biological and psychosocial function. JAMA 1963;185:914–919.
13.
da Silva MC, Fassa AG, Valle NCJ: Chronic low back pain in a Southern Brazilian adult population: prevalence and associated factors. Cad Saúde Pública 2004;20:377–385.
14.
Reed R, Pearlmutter L, Yochum K, et al: The relationship between muscle mass and muscle strength in the elderly. J Am Geriatr Soc1991;39:555–561.
15.
Bernick S, Walker JM, Paule WJ: Age changes to the annulus fibrosus in human intervertebral discs. Spine1991;5:520–524.
16.
Kraus H: Muscle deficiency; in Rachlin ES (ed): Myofascial Pain and Fibromyalgia. Mosby, St. Louis 1994, pp 385–414.
17.
Mannion A: The influence of muscle fiber size and type distribution on electromyographic measures of back muscle fatigability. Spine 1998;23:576–584.
18.
Harreby M, Nygaard B, Jessen T, Larsen E, Storr A, Fisker L: Risk factors for low back pain in a cohort of 1389 Danish school children: an epidemiologic study. Eur Spine J 1999;8:444–450.
19.
Waddell G, Somerville D, Henderson I, Newton M: Objective clinical evaluation of physical impairment in chronic low back pain. Spine 1992;17:617–628.
20.
Shapiro R: Radiologic aspect of renal osteodystrophy. Radiol Clin North Am 1972;10:557–568.
21.
Sakkas GK, Anthony JS, Mercer TH, et al: Changes in muscle morphology in dialysis patients after 6 months of aerobic exercise training. Nephrol Dial Transplant 2003;18:1854–1861.
22.
van Vilsteren MC, de Greef MH, Huisman RM: The effects of a low-to-moderate intensity pre-conditioning exercise programme linked with exercise counseling for sedentary haemodialysis patients in the Netherlands: results of a randomized clinical trial. Nephrol Dial Transplant 2005;20:141–146.
23.
Salminen JJ, Maki P, Oksanen A, Pentti J: Spinal mobility and trunk muscle strength in 15-year-old schoolchildren with and without low-back pain. Spine 1992;17:405–411.
24.
Heymans MW, van Tulder MW, Esmail R, Bombardier C, Koes BW: Back schools for nonspecific low back pain: a systematic review within the framework of the Cochrane Collaboration Back Review Group. Spine 2005;30:2153–2163.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.